Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Autophagy as a modulator and target in prostate cancer
Jason M. Farrow
, Joy C. Yang
, Christopher P. Evans
Division of Urologic Surgery
Research output
:
Contribution to journal
›
Review article
›
peer-review
143
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Autophagy as a modulator and target in prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemistry
Metabolic
100%
Toxic
100%
Cope Reaction
100%
Metformin
100%
Preclinical Study
100%
Chloroquine
100%
Androgen
100%
Hydroxychloroquine
100%
Taxane
100%
Keyphrases
Prostate Cancer
100%
Autophagy
100%
Advanced Prostate Cancer
22%
Disease Progression
11%
Clinical Trials
11%
Chemotherapy Resistance
11%
Therapeutic Intervention
11%
Cancer Cells
11%
In Cancer
11%
Cancer Treatment
11%
Autophagy Pathway
11%
Current Treatment
11%
Preclinical Data
11%
Metformin
11%
Pharmacological Inhibitors
11%
Treatment Resistance
11%
Metabolic
11%
Cytotoxicity
11%
Kinase Inhibition
11%
Cancer Therapeutics
11%
Cancer Development
11%
Eating
11%
Chloroquine
11%
Moving Forward
11%
Cancer Tissue
11%
Growth Characteristics
11%
Cell Killing
11%
Killing Effect
11%
Androgen Deprivation Therapy
11%
Hydroxychloroquine
11%
Diseases Therapeutic
11%
Adaptive Capacity
11%
Adaptive Process
11%
Nutrient Limitation
11%
Autophagy Modulators
11%
Taxane-based Chemotherapy
11%
Nutrient Utilization
11%
Cellular Robustness
11%
Desmethylclomipramine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Prostate Cancer
100%
Phosphotransferase
33%
Clinical Trial
33%
Chemotherapy
33%
Disease Exacerbation
33%
Preclinical Study
33%
Chloroquine
33%
Androgen
33%
Metformin
33%
Hydroxychloroquine
33%
Norclomipramine
33%
Cytotoxicity
33%
Taxane
33%
Medicine and Dentistry
Prostate Cancer
100%
Autophagy
100%
Malignant Neoplasm
18%
Clinical Trial
9%
Cancer Cell
9%
Disease Exacerbation
9%
Phosphotransferase
9%
Glycon
9%
Cytotoxicity
9%
Chloroquine
9%
Cell Killing
9%
Hydroxychloroquine
9%
Androgen Deprivation Therapy
9%
Norclomipramine
9%
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
Cancer Cell
9%
Clinical Trial
9%
Kinase
9%
Phosphotransferase
9%
Cytotoxicity
9%
Preclinical Study
9%
Cell Killing
9%